(1)H-NMR and (13)C-NMR dataset for some oxidative metabolites of CRA13 and their analogs

CRA13 (CB-13; SAB-378) is a dual CB(1)R/CB(2)R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the (1)H-NMR and (13)C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Ahmed H.E., Cho, Min Chang, Kim, Hye In, Yang, Ji Seul, Park, Kyung Tae, Lee, Yong Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198130/
https://www.ncbi.nlm.nih.gov/pubmed/30364648
http://dx.doi.org/10.1016/j.dib.2018.09.069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198130/
https://www.ncbi.nlm.nih.gov/pubmed/30364648
http://dx.doi.org/10.1016/j.dib.2018.09.069

Ejemplares similares